In:
Clinical Cancer Research, American Association for Cancer Research (AACR), Vol. 19, No. 19_Supplement ( 2013-10-01), p. B14-B14
Abstract:
Background: Ovarian cancer is a series of distinct diseases typically identified by their histopathological appearance as high-grade serous (HGSC; 70% of cases), low-grade serous (LGSC; 5%), endometrioid (ENOCa, 8%), clear cell (CCC, 12%), and mucinous (MC; 5%) carcinomas. Each type has defining molecular events, gene/protein expression patterns, genetic risk factors, sites of origin, and responses to treatment. Gold standard treatment is surgery followed by platinum-taxane chemotherapy despite mounting evidence suggesting CCCs, MCs, and LGSCs are largely platinum-taxane resistant. If outcomes are to be improved, it is critical to adopt a type specific strategy. Retrospective review studies have suggested histotype may be misdiagnosed or omitted in up to 30% of cases. However, pathological diagnosis of histotypes has been greatly refined in recent years and the use of biomarkers as aides is becoming more widespread. Nonetheless a rapid and fully objective classifier of histotypes will undoubtedly improve diagnostic accuracy, especially in the case of pre-surgical biopsies where small amounts of material present a challenge. Methods: Over 1000 ovarian carcinoma samples underwent expert gynecopathological review to establish a gold standard diagnosis for the 5 major carcinoma types. RNA was extracted from FFPE tissues and levels of a pre-selected set of & gt;100 genes were quantified using the NanoString GX system. Cohort was split with ~1/3 set aside for independent validation. Several statistical models were tested to generate a prediction algorithm for histological type including PAM, Random Forest, Lasso, Recursive Partitioning, and Discriminant Analysis. Feature selection methods and prediction error were examined using cross-validation in the train /test series prior to validation in the independent set. Results: Preliminary analysis suggests classification of the 5 major histotypes is possible using NanoString derived RNA expression levels. Accuracy appears to be equivalent to interobserver variation amongst expert gynecopathologist. Conclusions: The NanoString GX platform provides a stable and reproducible platform on which a robust single sample histological type classifier can be established. Our algorithm combined with the NanoString platform provides a rapid, and cost-effective option that does not require modification to current pathology lab tissue processing protocols. Diagnostic prediction require little material and is applicable to pre- and post- surgical specimens where an objective measure is desired to confirm diagnosis or aide in especially challenging cases. Citation Format: Michael S. Anglesio, Aline Talhouk, Steve E. Kalloger, Gholamreza Haffari, Robertson Mackenzie, Martin Cheung, Janine Senz, Christine Chow, Sherman Lau, Maria Intermaggio, Susan J. Ramus, Andreas du Bois, Jacobus Pfisterer, Jessica N. McAlpine, Friedrich Kommoss, Blake Gilks, Stefan Kommoss, David G. Huntsman. Rapid RNA-based histotyping of ovarian carcinomas. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Ovarian Cancer Research: From Concept to Clinic; Sep 18-21, 2013; Miami, FL. Philadelphia (PA): AACR; Clin Cancer Res 2013;19(19 Suppl):Abstract nr B14.
Type of Medium:
Online Resource
ISSN:
1078-0432
,
1557-3265
DOI:
10.1158/1078-0432.OVCA13-B14
Language:
English
Publisher:
American Association for Cancer Research (AACR)
Publication Date:
2013
detail.hit.zdb_id:
1225457-5
detail.hit.zdb_id:
2036787-9
Bookmarklink
